List of Treatments for Parkinson's Disease

Neupro (Rotigotine Transdermal System)

Overview
Neupro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2007 to treat motor symptoms of Parkinson’s disease. Neupro is also referred to by its drug name, rotigotine.

Neupro… read more

Northera (Droxidopa)

Overview
Northera is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat orthostatic hypotension (dizziness upon standing up) in people with Parkinson’s disease. Northera is also… read more

Nourianz (Istradefylline)

Overview
Nourianz is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with Parkinson’s experiencing “off” episodes. Nourianz is also referred to by its drug name, istradefylline.… read more

Nuplazid (Pimavanserin)

Overview
Nuplazid is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of hallucinations and delusions associated with Parkinson’s disease. Nuplazid is also known by its drug… read more

Nutrition

Overview
Like everyone else, people with Parkinson’s feel their best when they consistently eat a healthy, balanced diet. There is no specific diet for Parkinson’s, but following certain guidelines can ensure that your… read more

Ongentys (Opicapone)

Overview
Ongentys is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with Parkinson’s experiencing “off” episodes. Ongentys is also referred to by its drug name, opicapone.… read more

Osmolex ER (Amantadine)

Overview
Osmolex ER is an extended-release formulation of amantadine that is approved by the U.S. Food and Drug Administration (FDA) to treat symptoms of Parkinson’s disease, such as stiffness, tremors, and shaking. It is…

Parcopa (Levodopa/Carbidopa)

Overview
Parcopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2004 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more

Parlodel (Bromocriptine mesylate)

Overview
Parlodel is a prescription drug approved by the Food and Drug Administration (FDA) to treat the symptoms of Parkinson’s. Parlodel is also indicated to treat acromegaly, as well as problems associated with… read more

Requip (Ropinirole)

The Requip brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview

Requip is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1997 to treat motor symptoms…

Rytary (Levodopa/Carbidopa)

Overview
Rytary is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more

Selegiline (Eldepryl, Zelapar)

Overview
Selegiline is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in people with Parkinson’s disease. Selegiline may be prescribed as a monotherapy to people with… read more

Seroquel (Quetiapine)

Overview
Seroquel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Seroquel is also known by its drug name, quetiapine. Seroquel is sometimes prescribed… read more

Sinemet (Levodopa/Carbidopa)

Overview
Sinemet is a prescription drug approved by the Food and Drug Administration (FDA) in 1975 to treat motor symptoms of Parkinsonism caused by Parkinson’s Disease, encephalitis, or exposure to carbon monoxide or… read more

Stalevo (Levodopa/Carbidopa/Entacapone)

Overview
Stalevo is a prescription drug approved by the Food and Drug Administration (FDA) in 2003 to treat motor symptoms of Parkinson’s Disease. Stalevo is often prescribed in cases of advanced Parkinson’s Disease… read more

Symmetrel (Amantadine)

The Symmetrel brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Symmetrel is a prescription medication approved by the Food and Drug Administration (FDA) in…

Tasmar (Tolcapone)

Overview
Tasmar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 1998. Tasmar is prescribed as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose… read more

Trihexyphenidyl

Overview
Trihexyphenidyl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Trihexyphenidyl is often prescribed to younger people with… read more

Vyalev (Foscarbidopa/Foslevodopa)

Overview
Vyalev is approved by the U.S. Food and Drug Administration (FDA) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. This treatment is intended for individuals who experience…

Xadago (Safinamide)

Overview
Xadago is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an add-on medication to treat Parkinson’s disease. Xadago is indicated for people who are taking levodopa/carbidopa but… read more

Zelapar (Selegiline)

Overview
Zelapar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in people with Parkinson’s disease. Zelapar may be prescribed as a monotherapy to people with early… read more